BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
48 results:

  • 1. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
    Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Zhao X; Chen S; Meng T; Guan Q; Meng F; Kong Y; Ou X; Jia J; You H
    Am J Gastroenterol; 2024 Apr; 119(4):700-711. PubMed ID: 37929952
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Revalidation of the ATTRACTION-4 study in a real-world setting: a multicenter, retrospective propensity score matching study in China.
    Dai Y; Liu Y; Gong Z; He L; Wang L; Yang W; Qiu P; Zhang F; Yuan X; Cheng H; Qiu H
    Front Immunol; 2023; 14():1264929. PubMed ID: 37786611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
    Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
    [No Abstract]    [Full Text] [Related]  

  • 5. Characteristics and treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
    Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
    JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bariatric surgery reduces the risk of pancreatic cancer in individuals with obesity before the age of 50 years: A nationwide administrative data study in France.
    Bulsei J; Chierici A; Alifano M; Castaldi A; Drai C; De Fatico S; Rosso E; Fontas E; Iannelli A
    Eur J Surg Oncol; 2023 Apr; 49(4):788-793. PubMed ID: 36376141
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Kramer JR; Cao Y; Li L; Smith D; Chhatwal J; El-Serag HB; Kanwal F
    Am J Gastroenterol; 2022 Nov; 117(11):1834-1844. PubMed ID: 36327437
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
    Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
    Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]    [Full Text] [Related]  

  • 11. Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
    Nakai M; Yamamoto Y; Baba M; Suda G; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Suzuki K; Nakamura A; Sho T; Morikawa K; Ogawa K; Furuya K; Sakamoto N
    Sci Rep; 2022 Jan; 12(1):1449. PubMed ID: 35087141
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. In Vivo Comparison of Micro-Balloon Interventions (MBI) Advantage: A Retrospective Cohort Study of DEB-TACE Versus b-TACE and of SIRT Versus b-SIRT.
    Lucatelli P; De Rubeis G; Trobiani C; Ungania S; Rocco B; De Gyurgyokai SZ; Masi M; Pecorella I; Cappelli F; Lai Q; Catalano C; Vallati G
    Cardiovasc Intervent Radiol; 2022 Mar; 45(3):306-314. PubMed ID: 35037086
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
    Adachi Y; Kamiyama H; Ichikawa K; Fukushima S; Ozawa Y; Yamaguchi S; Goda S; Kimura T; Kodama K; Matsuki M; Miyano SW; Yokoi A; Kato Y; Funahashi Y
    Cancer Res; 2022 Jan; 82(2):292-306. PubMed ID: 34753772
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serum α-fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct-acting antiviral treatment.
    Kuwano A; Yada M; Nagasawa S; Tanaka K; Morita Y; Masumoto A; Motomura K
    J Viral Hepat; 2022 Jan; 29(1):35-42. PubMed ID: 34661320
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
    Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive analysis of cutaneous and uveal melanoma liver metastases.
    Hoefsmit EP; Rozeman EA; Van TM; Dimitriadis P; Krijgsman O; Conway JW; Pires da Silva I; van der Wal JE; Ketelaars SLC; Bresser K; Broeks A; Kerkhoven RM; Reeves JW; Warren S; Kvistborg P; Scolyer RA; Kapiteijn EW; Peeper DS; Long GV; Schumacher TNM; Blank CU
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33262254
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients.
    Moriya K; Namisaki T; Sato S; Furukawa M; Douhara A; Kawaratani H; Kaji K; Shimozato N; Sawada Y; Saikawa S; Takaya H; Kitagawa K; Akahane T; Mitoro A; Yamao J; Yoshiji H
    Clin Mol Hepatol; 2019 Dec; 25(4):381-389. PubMed ID: 31405269
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes.
    Wang B; Huang Q; Liu K; Fan Y; Peng C; Gu L; Shi T; Zhang P; Chen W; Du S; Niu S; Liu R; Zhao G; Li Q; Xiao C; Wang R; Li S; Wang M; Liu F; Wang H; Li H; Ma X; Zhang X
    Eur Urol; 2020 Jul; 78(1):77-86. PubMed ID: 31103390
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic liver Disease Justified? A Systematic Review and Meta-Analysis.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
    J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.